Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.23B | 59.98B | 64.60B | 65.69B | 66.27B | 65.85B |
Gross Profit | 27.12B | 26.42B | 28.38B | 26.81B | 27.36B | 23.13B |
EBITDA | -610.50M | -485.00M | -897.00M | -4.63B | -6.33B | -11.71B |
Net Income | -1.41B | -1.06B | -1.77B | -5.52B | -7.14B | -12.72B |
Balance Sheet | ||||||
Total Assets | 33.48B | 29.73B | 32.64B | 40.25B | 43.32B | 44.01B |
Cash, Cash Equivalents and Short-Term Investments | 541.00M | 1.63B | 583.00M | 6.12B | 5.84B | 1.37B |
Total Debt | 21.39B | 13.15B | 20.69B | 22.15B | 21.99B | 17.45B |
Total Liabilities | 38.93B | 28.82B | 37.40B | 43.40B | 41.04B | 39.61B |
Stockholders Equity | -5.45B | 904.00M | -4.76B | -3.15B | 2.28B | 4.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 525.00M | -4.48B | -619.00M | -5.91B | -6.23B |
Operating Cash Flow | 0.00 | 648.00M | -4.26B | -555.00M | -5.54B | -5.67B |
Investing Cash Flow | 0.00 | 136.00M | 189.00M | 672.00M | 710.00M | 1.05B |
Financing Cash Flow | 0.00 | 261.00M | -1.46B | 157.00M | 9.34B | 4.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥11.48B | 17.06 | 0.64% | 0.61% | 74.55% | ||
67 Neutral | ¥252.06B | 13.21 | 6.57% | 2.79% | 5.06% | -11.45% | |
64 Neutral | ¥2.41B | 23.46 | ― | 0.39% | -288.31% | ||
52 Neutral | ¥7.97B | ― | ― | -14.86% | -27.89% | ||
51 Neutral | €10.68B | ― | -180.01% | ― | -21.09% | -165.71% | |
50 Neutral | ¥8.02B | ― | 2.07% | -9.83% | -371.31% | ||
45 Neutral | ¥12.17B | ― | ― | -7.16% | 40.05% |